Skip to main content

Blogging Stocks has a timely piece about the upside to investing in beaten-up European-based multinational companies that have seen their stocks take a pounding recently. It's an interesting premise: Just because a company is based in Europe doesn't mean that its fate is tied to the euro zone economy, or the currency, for that matter.

The author of the piece, Sheldon Liber, highlighted three stocks: Novartis AG , Telefonica SA and Unilever PLC , each of which has crumpled by 20 per cent or more recently, making them look far more attractive than their peers. All three stocks trade as American Depositary Receipts on the New York Stock Exchange.

"A devalued euro may mean that these three companies, which have global market share now, will have a more competitive advantage going forward," he said. "If one were to buy all three, one would have an extremely diversified portfolio with global reach and very strong dividend yields fuelling one's retirement."

Story continues below advertisement

Report an error Licensing Options
About the Author
Investing Reporter

David Berman has been writing about business and investing since 1995. He has written for a number of magazines, including Canadian Business and MoneySense. He worked at the Financial Post as an investing writer and daily columnist before moving to the Globe and Mail in 2008. More

Comments are closed

We have closed comments on this story for legal reasons. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Combined Shape Created with Sketch.

Globe Newsletters

Get a summary of news of the day

Combined Shape Created with Sketch.

Thank you!

You are now subscribed to the newsletter at

You can unsubscribe from this newsletter or Globe promotions at any time by clicking the link at the bottom of the newsletter, or by emailing us at privacy@globeandmail.com.